Last Update: 9 Jun 2025.
6.4.1 The site shall have a sampling plan and testing regime based on risk assessment for the routine monitoring of the microbiological compliance of finished products listed on the site’s BMPA BQAP certificate of conformity.
6.4.2 Finished products shall be tested in accordance with the documented sampling plan, to demonstrate compliance with the following microbiological limits:
| Target | Upper Limit | |
|---|---|---|
| ACC | <1 x 104 cfu/g | 1 x 106 cfu/g |
6.4.3 Where on-going non-conformance trends are established there shall be evidence that this is subject to root cause investigation and corrective action.
Evidence
Review sampling schedule aligned to the scope of approved products and microbiological reports since the last audit. Evidence of corrective actions taken where non-conformance has been highlighted.

